Pliant Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Pliant Therapeutics, Inc. (PLRX) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.070.060.030.200.05
Short-Term Investments0.280.430.300.150.23
Cash & Short-Term Investments0.360.490.330.200.28
Accounts Receivable0.000.000.000.000.01
Inventory0.000.000.000.000.00
Other Current Assets0.000.000.000.000.00
Total Current Assets0.360.510.340.210.29
Non-Current Assets
Property, Plant & Equipment (Net)0.030.000.010.010.00
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.030.010.010.010.00
Total Assets0.400.510.350.220.30
Current Liabilities
Accounts Payable0.010.000.000.010.00
Short-Term Debt0.000.000.000.000.00
Accrued Liabilities0.030.020.010.010.01
Other Current Liabilities0.030.010.010.010.00
Total Current Liabilities0.030.030.020.020.01
Non-Current Liabilities
Long-Term Debt0.030.010.010.010.00
Other Non-Current Liabilities0.000.010.010.010.00
Total Non-Current Liabilities0.060.010.010.010.00
Total Liabilities0.090.040.040.020.01
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-0.71-0.50-0.34-0.22-0.12
Accumulated Other Comprehensive Income0.000.000.000.000.00
Additional Paid-in Capital1.010.970.650.410.40
Shares Outstanding0.060.060.050.040.00
Total Stockholders' Equity0.300.470.310.200.28
Total Liabilities & Equity0.400.510.350.220.30